censures. it s a very, very hard thing to do. yeah. and they have other options, right? they have other things they can do if you do something that s not quite this bad. you can be stripped from your committees without being censured and from your leadership job. you can be rep mended in someway and have the house ethics committee to say something mean about you. to be censured puts you on the end of the number line in terms of how your behavior compares to, as you say, the 11,000 other people that had this job since the beginning of the country. whenever we cover ethics scandals in washington or even something like this censure, there is this thing in the air about oh, it s always happening. just it just isn t you could work and live an entire career in the house of representatives and never see a censure vote. most 99, more than 99% of the members of the house and senate have never come close to being accused of an ethics violation in the ethics committee. they li
developments on day two of deliberations. we re also standing by to hear momentarily from president biden on the road in detroit selling his new infrastructure law, making the case for congress to pass the rest of his very ambitious agenda. we want to welcome our viewers here in the united states and around the world. i m wolf blitzer. you re in the situation room. this is cnn breaking news. let s get straight to the breaking news. first on capitol hill, our chief congressional correspondent manu raju is working the story for us. manu, a rather rare and very dramatic move by the house of representatives. yeah, very rare indeed. not common that a member of congress gets censured. this is the first time in 11 years. and also very rare for the house to actually move to strip someone of their committee assignments. just the second time a house majority has done that to a minority member. second time this year. this happening to paul gosar in the aftermath of him tweetin
thinking? that he s after i turned after i point the shotgun at him, he s coming back to the truck again. my father is in the back of the vehicle. so what? your dad is in the back of the vehicle? so? so he s the path he s making, he s going to make contact and be on the vehicle. he can jump up. still under pressure, might be armed, can run up and shoot. i m not going to see him at this point. i have a vehicle between me and him. at this point, i leave i m a little past my door. you are this is your door. this is the truck. at some point are you in the crux of the door? i was when he was running to me when i drew the weapon. i was outside the crux, at the edge of the door jam. when he turned and went to the passenger side, i went ahead and moved to the center of the road. outside of this why? i was gaining distance. obvious i thought it was obvious that he was going to glance and go through that yard. okay. that is what i was thinking was going
that s good news. it s at least sort of simplifying news in terms of the rules and formal government advice about vaccinations. that news comes on the same day, we ve learned, that pfizer is going to the fda to get approval for its new antiviral pill. this is not a vaccine, this is a pill you take as a treatment for covid. merck has one of these antiviral pills, pfizer has one of them, too. the merck clinical results looked really good in terms of people being kept alive, getting out of the hospital if they could get that drug soon after being diagnosed with covid. the merck results were good, but the pfizer clinical trial results looked even better. the pfizer clinical trial results showed nearly 90% efficacy at keeping people out of the hospital and alive if they could get this drug, this new pfizer antiviral drug, again, that you take as a pill soon after contracting covid. again, pfizer has just put in to the fda to have that treatment authorized for use in the united sta
going to the fda to get approval for its new antiviral pill. this is not a vaccine, this is a pill you take as a treatment for covid. merck has one of these antiviral pills, pfizer has one of them, too. the merck clinical results looked really good in terms of people being kept alive, getting out of the hospital if they could get that drug soon after being diagnosed with covid. the merck results were good, but the pfizer clinical trial results looked even better. the pfizer clinical trial results showed nearly 90% efficacy at keeping people out of the hospital and alive if they could get this drug, this new pfizer antiviral drug, again, that you take as a pill soon after contracting covid. again, pfizer has just put in to the fda to have that treatment authorized for use in the united states. merck s application for its antiviral treatment is already being processed at the fda. that s all good, having a whole new armamentarium of clinically proven effective drugs to treat cov